At least one hyperkalemia episode is associated with mortality and disease progression in stage 3 CKD patients

Luís Falcão(Hospital Beatriz Ângelo), Mário Raimundo(Hospital Beatriz Ângelo), Sara Fernandes(Hospital Beatriz Ângelo), Adriana Fernandes(Hospital Beatriz Ângelo), Beatriz Donato(Hospital Beatriz Ângelo), Ana Macedo(Bridgepoint (United Kingdom)), Ana Cortesão Costa(Hospital Beatriz Ângelo), Catarina Teixeira(Hospital Beatriz Ângelo), Sónia Silva(Hospital Beatriz Ângelo), Edgar Almeida(University of Lisbon)

Journal of Nephrology

June 12, 2023

10.1007/s40620-023-01647-3

Cited by 2

Abstract

Related Papers

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

Csaba P. Kövesdy, Kunihiro Matsushita, Yingying Sang et al.|European Heart Journal|2018|322

Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

Patrick Rossignol, Mitja Lainščak, María G. Crespo‐Leiro et al.|European Journal of Heart Failure|2020|145

Updates in hyperkalemia: Outcomes and therapeutic strategies

Csaba P. Kövesdy|Reviews in Endocrine and Metabolic Disorders|2016|116

Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort

Ingrid Hougen, Silvia J. Leon, Reid Whitlock et al.|Kidney International Reports|2021|69

Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study

Kenichi Tanaka, Hirotaka Saito, Tsuyoshi Iwasaki et al.|Clinical and Experimental Nephrology|2021|31